Overview

 

Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue. Research has focused on its selective stimulation of growth hormone release through activation of the ghrelin receptor (GHS-R1a). Unlike some earlier growth hormone secretagogues, Ipamorelin has demonstrated high selectivity for growth hormone release with minimal effects on cortisol and prolactin secretion in research models.

Mechanism of Action

Research suggests Ipamorelin binds to Growth Hormone Secretagogue Receptors (GHS-R1a) located primarily within the pituitary and hypothalamus. Activation of these receptors stimulates pulsatile growth hormone release while maintaining natural endocrine feedback mechanisms. Studies have investigated its effects on IGF-1 production, recovery pathways, body composition, muscle biology, and metabolic regulation.

Compound Information

Stability Information

Information provided for educational and research reference purposes only. Studies listed are third-party publications and do not constitute medical advice.